Arexvy (RSV vaccine) is the first FDA-approved vaccine to help lower your risk of getting serious lung infections caused by respiratory syncytial virus (RSV). You can get it if you're age 60 or older, and in some cases starting at age 50 if you have a higher risk of severe illness from RSV. Arexvy (RSV vaccine) is given once as a single injection into the muscle. Common side effects include tiredness, muscle pain, and injection site reactions like pain, swelling, or redness.
Prevention of serious lung infections caused by respiratory syncytial virus (RSV) in:
Arexvy (RSV vaccine) is a recombinant protein vaccine. It contains proteins from the RSV virus that trigger your immune system to make antibodies to fight the virus.
If you’re exposed to RSV later, these antibodies can stop the virus from infecting your lungs. And if you get the vaccine during pregnancy, your body can pass some of these antibodies to your baby before they are born. This helps protect your newborn from RSV after birth.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
50 to 59 years old:
60 years and older:
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
The CDC recommends getting an RSV vaccine like Arexvy if you're 75 years and older, or between 50 and 74 years old and at higher risk for severe illness from RSV. Talk to your healthcare professional about whether or not getting an RSV vaccine is a good option for you.
Yes, Arexvy is given as a one-time dose. Booster shots or additional doses aren't recommended at this time.
Based on the current CDC recommendations, Arexvy is given as a single dose. It's not currently recommended as an annual vaccine like the flu shot.
Studies show that Arexvy provides protection against RSV in adults for at least two years after a single dose. Since Arexvy is a newer vaccine, researchers are still studying how long the protection lasts and whether booster doses might be needed in the future.
Yes, you can get Arexvy on the same day as other vaccines. If you do, there's a chance you might have more side effects or stronger side effects. Discuss the best timing to get your vaccines with your pharmacist or primary care provider.
No, Arexvy isn't an mRNA vaccine. mRNA vaccines use genetic material that teaches your body to make a piece of a virus, which then triggers your immune system to make antibodies. Instead, Arexvy is a recombinant protein vaccine. It already contains pieces of the RSV virus that, once injected, prompt your immune system to make antibodies to help fight RSV.
In clinical studies, Arexvy reduced the risk of getting RSV illness by about 83% during one RSV season (typically fall and winter) compared to placebo. The same study also showed that it lowered the risk of serious RSV illness by 94% compared to placebo. Keep in mind, research is still ongoing. Scientists will continue to look at how long protection lasts, especially over multiple RSV seasons.
Arexvy and Abrysvo are two RSV vaccines given as one-time shots by a trained healthcare professional. Both are FDA-approved for adults 60 and older, Abrysvo is also approved for pregnant mothers between 32 to 36 weeks and adults ages 18 to 59 who're at high risk for RSV. The two vaccines have similar side effects, and the CDC doesn't recommend one over the other for older adults. Talk to your primary care provider to learn more about the differences between these two vaccines.
Arexvy (RSV vaccine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Some people who got Arexvy (RSV vaccine) developed a rare condition called Guillain-Barré syndrome (GBS), where the immune system mistakenly attacks the nerves. This is most likely to happen within the first 42 days after getting the vaccine. If you notice symptoms like muscle weakness, tingling, and coordination problems, contact your healthcare professional right away.
Although rare, it's possible for Arexvy (RSV vaccine) to cause a severe allergic reaction. Get medical help right away if you experience skin rash, tightness in your chest, trouble breathing, or swelling in your lips, tongue, throat, or face after receiving this vaccine.
Injectable vaccines like Arexvy (RSV vaccine) can cause some people to faint afterwards. Stay seated for a while after getting your vaccine, and stand up slowly to make sure you don't fall if you feel faint or dizzy.
Arexvy (RSV vaccine) might not work as well if you have a weakened immune system. If you have certain medical conditions like human immunodeficiency virus (HIV), cancer) or take medications that weaken your immune system — such as high-dose corticosteroids, transplant medications, cancer treatments) — talk to your healthcare professional first before getting Arexvy (RSV vaccine). They can help you decide if the vaccine is right for you.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 1 dose | 1 carton | $300.34 | $300.34 |
The typical dose is 0.5 mL injected into the muscle by a healthcare professional.
Prevention of serious lung infections caused by respiratory syncytial virus (RSV) in:
Prevention of serious lung infections caused by respiratory syncytial virus (RSV) in: